1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Global Virus-Like Particles (VLPs) Trends Industry

Global Virus-Like Particles (VLPs) Trends Industry

  • January 2014
  • -
  • Global Industry Analysts
  • -
  • 12 pages

The report analyzes and presents an overview of Virus-Like Particles (VLPs) market worldwide. "Virus-like particles or VLPs bear high structural resemblance to viruses, though completely non-infectious in nature due to the absence of viral genetic material. While lacking the DNA material, VLPs retain key immunological characteristics of viruses including particulate structures; repetitive surfaces; and capability to induce innate immunity by activating molecular-pattern pathogen-associated recognition receptors."

The report also provides a review of types, medium of production, quantification, applications, and advantages of VLPs over conventional vaccines along with strategic industry activities of major companies worldwide. In addition, 10 companies operating in the Direct Attached Storage (DAS) arena worldwide including Cytos Biotechnology AG, Medicago Inc., Novavax Inc., Redbiotec AG, Virometix AG, VLPbio - The Vaccines Company and other are profiled.

Table Of Contents

Global Virus-Like Particles (VLPs) Trends Industry

1.VIRUS-LIKE PARTICLES - A TECHNOLOGY OVERVIEW

Virus-like Particles: An Introduction

Ability to Elicit Immune Response: A Unique Characteristic of VLPs

Virus-like Particles: Types

Mycovirus VLPs

Chimeric VLPs

Empty Virus-like Particles (eVLPs)

Functional Influenza VLPs

Respiratory Syncytial VLPs

Rabies Glycoprotein VLPs

Virus-like Particles: Medium of Production

Insect Cell Lines

Plant Cell Lines

Yeast Cells

Heterologous Expression Systems

Virus-like Particles: Quantification

Virus-like Particles: Applications

Vaccine Development

Treatment of Chronic Diseases

Advantages of VLP-based Vaccines over Conventional Vaccines

Comparison with Recombinant Protein Vaccines

Comparison with Chicken Egg-based Vaccines

Advantage of Using VLPs in Development of Flu Vaccine

Use of VLPs in Nanotechnology for Targeted Drug Delivery

2.NOTEWORTHY INDUSTRY ACTIVITY

Medicago and a Leading Pharmaceutical Company Ink Loan Agreement

Medicago Develops New VLP-based Vaccine Candidate againstH7N9 Virus

Novavax Commences Animal Studies on H7N9 VLP Vaccine

Medicago to Increase Production Capacity of Pilot Facility

Medicago Completes Preclinical Studies on New VLP Vaccine Candidate against Rabies

Novavax Concludes Phase I Clinical Trials on A/H5N1 Vaccine Candidate

Medicago and USAMRIID Ink Research Collaboration Agreement

Novavax Secures Contract from Biomedical Advanced Research and Development Authority

Medicago and PT Bio Farma Ink Memorandum of Understanding

Medicago Files Patent Applications for New VLP/Recombinant Proteins Production Methods

Novavax Receives US Patent for Influenza VLP Vaccine Technology

Novavax Concludes Phase II Clinical Trial on Trivalent Seasonal Influenza VLP-based Vaccine Candidate

3.MARKET PARTICIPANTS

Cytos Biotechnology AG (Switzerland)

Icosagen AS (Estonia)

Medicago, Inc. (Canada)

Medigene AG (Germany)

Novavax, Inc. (USA)

Oxford Expression Technologies Ltd. (UK)

Paragon Bioservices, Inc. (USA)

Redbiotec AG (Switzerland)

Virometix AG (Switzerland)

VLPbio - The Vaccines Company (Spain)

4.APPENDIX



View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

  • $ 59500
  • Industry report
  • January 2017
  • by Venture Planning Group

This unique 68-country survey from VPGMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well ...

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...


Download Unlimited Documents from Trusted Public Sources

Cardiovascular Disease Industry in Asia

  • February 2017
    2 pages
  • Cardiovascular ...  

  • Asia  

    United States  

View report >

Endocrine Disease Statistics in the US

  • February 2017
    115 pages
  • Endocrine Disea...  

    Diabetes Monito...  

    Hospital  

  • United States  

    North America  

View report >

Tuberculosis Statistics in the UK

  • February 2017
    10 pages
  • Tuberculosis  

  • United Kingdom  

    Europe  

View report >

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.